Causes of thrombocytopenia in chronic hepatitis C viral infection (Q33399654)

26 July 2017

Causes of thrombocytopenia in chronic hepatitis C viral infection (English)

1 reference

26 July 2017

1 reference

1 reference

1 reference

Makoto Osada

1

1 reference

26 July 2017

Makoto Kaneko

2

1 reference

26 July 2017

Minoru Sakamoto

3

1 reference

26 July 2017

Masumi Endoh

4

1 reference

26 July 2017

Koichi Takigawa

5

1 reference

26 July 2017

Katsue Suzuki-Inoue

6

1 reference

26 July 2017

Osamu Inoue

7

1 reference

26 July 2017

Kaneo Satoh

8

1 reference

26 July 2017

Nobuyuki Enomoto

9

1 reference

26 July 2017

Yutaka Yatomi

10

1 reference

26 July 2017

Yukio Ozaki

11

1 reference

26 July 2017

12 February 2012

1 reference

Clinical and Applied Thrombosis-Hemostasis

26 July 2017

1 reference

26 July 2017

18

1 reference

26 July 2017

3

1 reference

26 July 2017

272-280

1 reference

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

26 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Platelet dynamics in chronic liver disease with special reference to the role of the spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Thrombocytopenia in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Von Willebrand factor in plasma and in liver tissue after partial hepatectomy in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

The role of the liver in the production of thrombopoietin compared with erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Transcriptional regulation of bone marrow thrombopoietin by platelet proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Liver fibrosis and chronic viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029611429124

21 January 2018

Identifiers

DOI

10.1177/1076029611429124

1 reference

26 July 2017

1 reference